76 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
14 Jun 24
Condensed Consolidated Financial Statements
4:30pm
AND CONTINGENT LIABILITIES
The Company is required to pay royalties to the State of Israel (represented by the Israeli Innovation Authority (the “IIA
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
3 Jun 24
Report of Foreign Private Issuer
8:05am
. I am excited to lead this study and look forward to initiating the trial.”
Dr. Oron has a long and successful track record of innovation. He
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
: macrophage A Received regulatory authorization for Phase I/II trial, knee osteoarthritis.
4 | Nasdaq: ENLV DRIVING INNOVATION WITH BALANCED SCIENTIFIC
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
not been conclusively proven to be feasible and has no alternative future use.
Grants received from Israel Innovation Authority, Ministry of Industry … (represented by the Israeli Innovation Authority, the “IIA”), computed on the basis of proceeds from the sale or license of products for development supported
6-K
EX-99.1
qdy1a k0d
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
k0httgj dhl3
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
aq7dp6lx6qq
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
q9ujz5su
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
8degjt tu9w
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
3vzhz
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
k8wvqc32f9pgpqqnq
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
cmoea
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
cz9 ikx76hl
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
vi9e7rrz3 rgpmdwvsjm
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
8k5z2gr
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
dkenq9
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
889dwkze
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.3
m059v52i9u1vic7k4 oq
22 Aug 22
Condensed Consolidated Financial Statements
8:08am